Q32 Bio (QTTB) Total Non-Current Liabilities (2018 - 2026)

Q32 Bio's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $17.4 million for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 38.18% year-over-year to $17.4 million in Q1 2026; TTM through Mar 2026 was $17.4 million, a 38.18% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 37.57% from the prior year.
• Total Non-Current Liabilities declined to $17.4 million in Q1 2026 per QTTB's latest filing, from $19.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $48.5 million in Q1 2024 and bottomed at $17.4 million in Q1 2026.
• The 5-year median for Total Non-Current Liabilities is $31.2 million (2024), against an average of $30.7 million.
• Across the five-year window, Total Non-Current Liabilities advanced 13.57% in 2023 and slumped 42.04% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $37.7 million in 2022, then rose by 13.57% to $42.8 million in 2023, then fell by 26.1% to $31.7 million in 2024, then tumbled by 37.57% to $19.8 million in 2025, then retreated by 12.14% to $17.4 million in 2026.
• Per Business Quant, the three latest QTTB Total Non-Current Liabilities figures stand at $17.4 million (Q1 2026), $19.8 million (Q4 2025), and $21.2 million (Q3 2025).